Nov 28 (Reuters) - Quest Pharmatech Inc QPT.V :
* QUEST PHARMATECH SIGNS LICENSE AGREEMENT WITH ONCOCARE THERAPEUTICS TO DEVELOP AND COMMERCIALIZE TARGETED CANCER THERAPY TECHNOLOGY IN THE U.S.
* QUEST PHARMATECH INC - IN RETURN FOR GRANTING LICENSE RIGHTS TO U.S., CO WILL RECEIVE A 45% OWNERSHIP INTEREST IN ONCOCARE THERAPEUTICS